Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing ...

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

In our news wrap Thursday, a group of states is suing the Trump administration over its planned 15% global tariff, Defense Secretary Pete Hegseth told Latin American countries to step up their fight ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

The supply chain that ultimately connects patients with their medicines is winding and complex — and growing more consolidated. In recent years, lawmakers have targeted the tactics used by drug ...

Trump wants to focus on his efforts to lower drug prices, but the TrumpRx website is falling short of his promises.

President Donald Trump's administration is expanding its crackdown on state Medicaid programs to New York, launching a fraud probe in the state.

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

Central High School senior Parker Evans is one of 30 students selected for Tuskegee University’s Aviation Science Program. Evans received a $50,000 scholarship to complete a bachelor’s degree in ...

The Trump administration says it wants to tackle the "addiction epidemic." But it's eliminating addiction treatment resources and access to mental healthcare.